Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells

por Simbulan-Rosenthal, Cynthia M., Haribabu, Yogameenakshi, Vakili, Sahar, Kuo, Li-Wei, Clark, Havens, Dougherty, Ryan, Alobaidi, Ryyan, Carney, Bonnie, Sykora, Peter, Rosenthal, Dean S.
Publicado 2022

CRISPR-Cas9 Knockdown and Induced Expression of CD133 Reveal Essential Roles in Melanoma Invasion and Metastasis

por Simbulan-Rosenthal, Cynthia M., Dougherty, Ryan, Vakili, Sahar, Ferraro, Alexandra M., Kuo, Li-Wei, Alobaidi, Ryyan, Aljehane, Leala, Gaur, Anirudh, Sykora, Peter, Glasgow, Eric, Agarwal, Seema, Rosenthal, Dean S.
Publicado 2019